Vascular effects of metformin: Possible mechanisms for its antihypertensive action in the spontaneously hypertensive rat

American Journal of Hypertension

Volumn 9, Issue 6, 1996, Pages 570-576

  Bhalla, Ramesh C ^a   Toth, Karen F ^a   Tan, EnQing ^a   Bhatty, Robert A ^a   Mathias, Eric ^a   Sharma, Ram V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Blood pressure; Cytosolic calcium; Image analysis; Metformin; Nitric oxide; Spontaneously hypertensive rat; Vascular smooth muscle cells; Wistar Kyoto rat

Indexed keywords

ARGININE DERIVATIVE; METFORMIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SUBCUTANEOUS DRUG ADMINISTRATION; VASCULAR SMOOTH MUSCLE;

EID: 0030175581     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00356-8     Document Type: Article

References (39)

1. 1. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
2. 2. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
3. 3. Anderson EA, Mark AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993;21:136-141.
4. 4. Melin B, Cherqui G, Blivet MJ, et al: Dual effect of metformin in cultured rat hepatocytes: potentiation of insulin action and prevention of insulin induced resistance. Metab Clin Exp 1990;39:1089-1095.
5. 5. Matthaei S, Greten H: Evidence that metformin ameliorates cellular insulin-resistance by potentiating insulin-induced translocation of glucose transporters to the plasma membrane. Diabete et Metabolisme 1991; 17:150-158.
6. 6. Sarabia V, Lam L, Burdett E, et al: Glucose transport in human skeletal muscle cells in culture. Stimulation by insulin and metformin. J Clin Invest 1992;90:1386-1395.
7. 7. Bailey CJ: Metformin - an update. Gen Pharmacol 1993;24:1299-1309.
8. 8. Morgan DA, Ray CA, Balon TW, Mark AL: Metformin increases insulin sensitivity and lowers arterial pressure in spontaneously hypertensive rats. Hypertension 1992;20:421A.
9. 9. Landin-Wilhelmsen K: Metformin and blood pressure. J Clin Pharmacy Ther 1992;17:75-79.
10. 10. Chan JC, Tomlinson B, Critchley JA, et al: Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care 1993;16:1035-1038.
11. 11. Peuler JD, Zammam HY, Stowe MP, et al: Inhibition of arterial contractility by nonsulfonylurea insulin-sensitizing drugs. Annual meeting of the Endocrine Society, June 15-18, 1994, Anaheim, CA (abst 414).
12. 12. Yagi S, Takata S, Kiyokawa H, et al: Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin-II in rabbit femoral artery and vein. Diabetes 1988;37:1064-1067.
13. 13. Wambach GK, Liu D: Insulin attenuates vasoconstriction by noradrenaline, serotonin and potassium chloride in rat mesenteric arterioles. Clin Exp Hyperten 1992;14:733-740.
14. 14. Zemel MB, Reddy S, Sowers JR: Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertens 1991;4:537-539.
15. 15. Standley PR, Zhang F, Ram JL, et al: Insulin attenuates vasopressin-induced calcium transients and voltage-dependent calcium responses in rat vascular smooth muscle cells. J Clin Invest 1991;88:1230-1236.
16. 16. Kahn AM, Seidel CL, Allen JC, et al: Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993;22:735-742.
17. 17. Ram JL, Standley PR, Sowers JR: Hypertension, insulin function, and calcium, in Drazanin B, Eckel RH (eds): Diabetes and Atherosclerosis: Molecular Basis and Clinical Aspects. Amsterdam, Elsevier, 1993, pp 291-305.
18. 18. Touyz RM, Tolloczko B, Schiffrin EL: Insulin attenuates agonist-evoked calcium transients in vascular smooth muscle cells. Hypertension 1994;23(suppl I):I-25-I-28.
19. 19. Sowers JR, Sowers PS, Peuler JD: Role of Insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med 1994;123: 647-652.
20. 20. Resnick LM, Gupta RK, Bhargava KK, et al: Cellular ions in hypertension, diabetes and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension 1991;17:951-957.
21. 21. Schulz R, Triggle CR: Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 1994;15:255-259.
22. 22. Ignarro LJ: Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Semin Hematol 1989;26:63-76.
23. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 1989;264:1146-1155.
24. 24. Bhalla RC, Sharma RV, Ramanathan S: Possible role of phosphorylation-dephosphorylation in the regulation of calcium metabolism in cardiovascular tissues of SHR. Hypertension 1980;2:207-214.
25. 25. Bunag RD, Butterfield J: Tail-cuff blood pressure measurement without external preheating in awake rats. Hypertension 1982;4:898-903.
26. 26. Bendhack LM, Sharma RV, Bhalla RC: Altered signal transduction in vascular smooth muscle cells of spontaneously hypertensive rats. Hypertension 1992;19 (suppl II):II-142-II-148.
27. 27. Bhalla RC, Sharma RV: Induction of c-fos and elastin gene in response to mechanical stretch of vascular smooth muscle cells. J Vas Med Biol 1993;4:130-137.
28. 28. Sharma RV, Bhalla RC: PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells. Am J Physiol 1993;264 (Cell Physiol 33):C71-C79.
29. 29. Tracey WR: Spectrophotometric detection of nitrogen oxides. Neuroprotocols 1992;1:1-7.
30. 30. Sterne J: Pharmacology and mode of action of hypoglycemic guanidine derivatives. Med Chem Ser Monogr 1969;9:193-245.
31. 31. Verma S, McNeill JH: Metformin improves cardiac function in isolated streptozotocin-diabetic rat hearts. Am J Physiol 1994;266:H714-H719.
32. 32. Zhang HY, Reddy SR, Kotchen TA: Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension 1994;24: 106-110.
33. 33. Tucker GT, Casey C, Phillips P, et al: Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol 1981;12:235-246.
34. 2+ transients by insulin in cultured unpassaged vascular smooth muscle cells from spontaneously hypertensive rats. Am J Hypertens 1995;8:104-112.
35. G-hydroxy-L-arginine causes nitrite production in vascular smooth muscle cells in the absence of nitric oxide synthase activity. FEBS Lett 1994;341:203-207.
36. 36. Dubey RK, Zhang HY, Reddy SR, et al: Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol 1993;265:R726-R732.
37. 37. Pershadsingh HA, Szollosi J, Benson S, et al: Effects of ciglitazone on blood pressure and intracellular calcium metabolism. Hypertension 1993;21:1020-1023.
38. 38. Yoshioka S, Nishino H, Shiraki T, Ikeda, et al: Antihypertensive effects of CS-045 treatment in obese Zucker rats. Metab Clin Exp 1993;42:75-80.
39. 39. Zhang F, Sowers JR, Ram JL, et al: Effects of pioglitazone on calcium channels in vascular smooth muscle. Hypertension 1994;24:170-175.